Financial Sense Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History

Financial Sense Advisors, Inc.

$343 Million
Q2 2025

A detailed history of Financial Sense Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Financial Sense Advisors, Inc. holds 673,029 shares of TEVA stock, worth $11.1 Million. This represents 3.29% of its overall portfolio holdings.

Number of Shares

673,029

Previous 405,421 66.01%

Holding current value

$11.1 Million

Previous $6.23 Million 81.01%

% of portfolio

3.29%

Previous 2.1%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	BUY	$12.82 - $18.15 $3.43 Million - $4.86 Million	267,608 Added 66.01%	673,029 $11.3 Million
Q1 2025 May 05, 2025	BUY	$14.67 - $22.01 $2.31 Million - $3.46 Million	157,421 Added 63.48%	405,421 $6.23 Million
Q4 2024 Jan 31, 2025	SELL	$16.43 - $22.77 $8,215 - $11,385	-500 Reduced 0.2%	248,000 $5.47 Million
Q3 2024 Oct 31, 2024	BUY	$15.81 - $18.96 $63,240 - $75,840	4,000 Added 1.64%	248,500 $4.48 Million
Q2 2024 Jul 23, 2024	SELL	$12.78 - $17.4 $291,511 - $396,893	-22,810 Reduced 8.53%	244,500 $3.97 Million
Q1 2024 Apr 19, 2024	BUY	$10.67 - $14.43 $184,697 - $249,783	17,310 Added 6.92%	267,310 $3.77 Million
Q4 2023 Jan 12, 2024	BUY	$8.12 - $10.63 $11,367 - $14,882	1,400 Added 0.56%	250,000 $2.61 Million
Q2 2023 Aug 02, 2023	SELL	$7.2 - $9.47 $25,200 - $33,145	-3,500 Reduced 1.39%	248,600 $1.87 Million
Q1 2023 Apr 24, 2023	SELL	$8.36 - $11.37 $33,440 - $45,480	-4,000 Reduced 1.56%	252,100 $2.23 Million
Q4 2022 Feb 06, 2023	SELL	$7.95 - $9.48 $399,090 - $475,896	-50,200 Reduced 16.39%	256,100 $2.34 Million
Q3 2022 Oct 13, 2022	BUY	$6.86 - $11.95 $336,140 - $585,550	49,000 Added 19.04%	306,300 $2.47 Million
Q2 2022 Jul 18, 2022	BUY	$7.38 - $10.4 $1.9 Million - $2.68 Million	257,300 New	257,300 $1.94 Million
Q1 2022 May 05, 2022	SELL	$7.33 - $9.39 $1.52 Million - $1.95 Million	-207,500 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$7.9 - $10.19 $408,430 - $526,823	-51,700 Reduced 19.95%	207,500 $1.66 Million
Q3 2021 Nov 03, 2021	SELL	$8.38 - $10.18 $16,466 - $20,003	-1,965 Reduced 0.75%	259,200 $2.53 Million
Q2 2021 Jul 29, 2021	BUY	$9.9 - $11.56 $510,493 - $596,091	51,565 Added 24.6%	261,165 $2.59 Million
Q1 2021 Apr 28, 2021	BUY	$10.34 - $12.81 $113,740 - $140,910	11,000 Added 5.54%	209,600 $2.42 Million
Q4 2020 Feb 03, 2021	SELL	$8.61 - $11.04 $27,552 - $35,328	-3,200 Reduced 1.59%	198,600 $1.92 Million
Q3 2020 Oct 21, 2020	SELL	$8.57 - $12.69 $419,441 - $621,086	-48,943 Reduced 19.52%	201,800 $1.82 Million
Q2 2020 Jul 20, 2020	SELL	$8.12 - $13.12 $28,476 - $46,011	-3,507 Reduced 1.38%	250,743 $3.09 Million
Q1 2020 Apr 20, 2020	BUY	$6.69 - $13.45 $330,820 - $665,102	49,450 Added 24.15%	254,250 $2.28 Million
Q4 2019 Jan 23, 2020	BUY	$6.53 - $10.72 $449,264 - $737,536	68,800 Added 50.59%	204,800 $2.01 Million
Q3 2019 Nov 08, 2019	SELL	$6.16 - $9.6 $52,360 - $81,600	-8,500 Reduced 5.88%	136,000 $936,000
Q2 2019 Aug 02, 2019	SELL	$8.12 - $15.72 $32,886 - $63,666	-4,050 Reduced 2.73%	144,500 $1.33 Million
Q1 2019 May 06, 2019	BUY	$15.58 - $20.01 $592,819 - $761,380	38,050 Added 34.43%	148,550 $2.33 Million
Q4 2018 Feb 07, 2019	BUY	$14.59 - $23.84 $120,732 - $197,276	8,275 Added 8.09%	110,500 $1.7 Million
Q3 2018 Nov 01, 2018	BUY	$21.06 - $25.65 $110,565 - $134,662	5,250 Added 5.41%	102,225 $2.2 Million
Q2 2018 Jul 26, 2018	BUY	$16.77 - $24.71 $406,420 - $598,846	24,235 Added 33.32%	96,975 $2.36 Million
Q1 2018 Apr 30, 2018	BUY	$16.68 - $22.07 $531,091 - $702,708	31,840 Added 77.85%	72,740 $1.24 Million
Q4 2017 Feb 09, 2018	BUY	$11.23 - $19.1 $459,307 - $781,190	40,900	40,900 $775,000

Others Institutions Holding TEVA

# of Institutions

651

Shares Held

646M

Call Options Held

22M

Put Options Held

15.8M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Sense Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Sense Advisors, Inc. with notifications on news.

Account

Financial Sense Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History